Free Trial

ProShares Ultra Nasdaq Biotechnology Rating

ProShares Ultra Nasdaq Biotechnology logo
$52.55 -0.07 (-0.13%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$53.34 +0.79 (+1.50%)
As of 07/25/2025 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

BIB Aggregate Rating

Moderate Buy
2.69

Holdings in BIB have an aggregate rating of Moderate Buy based on 679 analyst ratings issued in the past year covering 44 companies (55.7% of the portfolio).

BIB Aggregate Price Target

$52.55
High Prediction$52.55
Average Prediction$52.55
Low Prediction$52.55

Holdings in BIB have an aggregate price target of $52.55 and a range of $52.55 to $52.55 covering 44 companies (55.7% of the portfolio).

BIB Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
17 Buy rating(s)
Moderate Buy
17 Moderate Buy rating(s)
Hold
9 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 44 BIB Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
5.57%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$116.20
+2.7%
4.8879 of 5 stars
2.81$112.36 -3.3%26Trending News
Analyst Upgrade
5.53%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$469.65
-0.6%
4.3226 of 5 stars
2.52$512.30 9.1%27Positive News
Analyst Revision
5.33%
Amgen Inc. stock logo
AMGN
Amgen
$306.58
-0.6%
4.4062 of 5 stars
2.35$307.27 0.2%23Positive News
Analyst Forecast
4.39%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$563.10
-0.3%
4.8268 of 5 stars
2.75$828.86 47.2%24Trending News
Upcoming Earnings
Analyst Forecast
3.30%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$72.66
-1.4%
2.9427 of 5 stars
2.83$89.00 22.5%6Upcoming Earnings
2.94%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$328.81
+0.2%
4.0702 of 5 stars
2.81$347.75 5.8%26News Coverage
Positive News
Upcoming Earnings
1.48%
Biogen Inc. stock logo
BIIB
Biogen
$131.52
-0.8%
4.8086 of 5 stars
2.34$186.37 41.7%32Upcoming Earnings
Analyst Revision
1.45%
Insmed, Inc. stock logo
INSM
Insmed
$103.95
+0.4%
3.9267 of 5 stars
3.00$109.20 5.1%17News Coverage
Analyst Forecast
Insider Trade
1.42%
argenex SE stock logo
ARGX
argenex
$591.99
+0.0%
3.6719 of 5 stars
3.10$728.06 23.0%21Trending News
Upcoming Earnings
Analyst Revision
1.23%
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$28.67
+4.0%
2.512 of 5 stars
2.79$34.67 20.9%14Positive News
1.21%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$36.67
+0.2%
4.9759 of 5 stars
3.25$49.00 33.6%4Positive News
Dividend Announcement
Analyst Forecast
1.20%
Illumina, Inc. stock logo
ILMN
Illumina
$109.30
+1.5%
4.6269 of 5 stars
2.40$125.11 14.5%20News Coverage
Upcoming Earnings
1.08%
Sanofi stock logo
SNY
Sanofi
$50.37
+0.5%
3.547 of 5 stars
3.13$62.00 23.1%8Positive News
Upcoming Earnings
1.06%
Incyte Corporation stock logo
INCY
Incyte
$70.20
-0.4%
4.6277 of 5 stars
2.22$74.47 6.1%18Positive News
Upcoming Earnings
Insider Trade
1.03%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$304.50
-0.6%
4.991 of 5 stars
2.69$383.08 25.8%13Trending News
Upcoming Earnings
Insider Trade
Analyst Revision
0.99%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$132.14
+0.4%
4.4413 of 5 stars
2.88$163.87 24.0%24Upcoming Earnings
Analyst Forecast
0.95%
Exelixis, Inc. stock logo
EXEL
Exelixis
$45.60
+1.8%
4.7783 of 5 stars
2.52$45.33 -0.6%21News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
0.90%
Tempus AI, Inc. stock logo
TEM
Tempus AI
$64.49
+1.8%
1.584 of 5 stars
2.50$65.09 0.9%12
0.85%
Viatris Inc. stock logo
VTRS
Viatris
$9.41
+0.6%
2.4337 of 5 stars
1.80$10.40 10.5%5
0.85%
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$115.31
+0.6%
1.4352 of 5 stars
2.83$136.58 18.4%18News Coverage
0.85%
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$59.01
-1.3%
4.9857 of 5 stars
2.75$93.74 58.9%24Analyst Forecast
0.84%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$167.47
-0.5%
3.4327 of 5 stars
3.00$223.07 33.2%15Analyst Revision
0.84%
Moderna, Inc. stock logo
MRNA
Moderna
$34.15
+0.4%
4.2995 of 5 stars
2.04$46.11 35.0%25Upcoming Earnings
Analyst Forecast
0.80%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$291.47
-1.7%
1.2901 of 5 stars
3.00$327.56 12.4%7Analyst Upgrade
Insider Trade
0.72%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$447.49
-1.8%
3.7182 of 5 stars
2.00$411.10 -8.1%14Trending News
Earnings Report
Analyst Forecast
Analyst Revision
Gap Down
0.68%
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$46.30
+1.4%
4.6357 of 5 stars
3.00$61.50 32.8%16Analyst Downgrade
0.66%
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
$129.46
1.0836 of 5 stars
2.24$128.25 -0.9%21Positive News
Upcoming Earnings
0.62%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$11.55
+1.5%
2.5987 of 5 stars
3.25$16.50 42.9%4News Coverage
Positive News
Insider Trade
0.59%
Verona Pharma PLC American Depositary Share stock logo
VRNA
Verona Pharma PLC American Depositary Share
$105.30
+0.3%
2.8206 of 5 stars
2.15$109.00 3.5%13Positive News
0.55%
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$37.90
+1.8%
4.4972 of 5 stars
3.00$68.91 81.8%11News Coverage
0.53%
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
$118.23
+0.2%
4.8614 of 5 stars
2.93$181.64 53.6%14Analyst Forecast
0.53%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$298.40
-0.3%
4.3095 of 5 stars
2.89$420.63 41.0%9News Coverage
Insider Trade
0.52%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$58.24
-0.9%
4.8524 of 5 stars
2.17$62.70 7.7%12Positive News
0.51%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$42.24
+0.2%
4.5355 of 5 stars
2.62$55.67 31.8%13News Coverage
Upcoming Earnings
0.50%
Guardant Health, Inc. stock logo
GH
Guardant Health
$44.42
-2.4%
4.4699 of 5 stars
3.05$54.45 22.6%21News Coverage
Upcoming Earnings
Analyst Revision
0.42%
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$81.41
-0.8%
3.203 of 5 stars
3.17$119.60 46.9%12High Trading Volume
0.41%
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$100.83
-3.9%
4.744 of 5 stars
3.06$172.33 70.9%16News Coverage
Positive News
Analyst Revision
0.38%
Alkermes plc stock logo
ALKS
Alkermes
$26.13
-1.5%
4.7871 of 5 stars
2.83$40.92 56.6%12Upcoming Earnings
0.36%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$50.56
+0.1%
3.8187 of 5 stars
3.00$82.50 63.2%6Positive News
0.35%
ADMA Biologics Inc stock logo
ADMA
ADMA Biologics
$18.01
+4.0%
3.6147 of 5 stars
3.33$27.67 53.6%3News Coverage
Positive News
0.34%
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$36.63
+1.1%
1.8035 of 5 stars
3.10$136.50 272.6%10News Coverage
Positive News
0.33%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$64.76
-2.0%
2.4864 of 5 stars
2.53$71.31 10.1%17Analyst Forecast
Gap Up
0.32%
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
$86.45
-0.9%
3.128 of 5 stars
3.07$91.93 6.3%15Analyst Upgrade
0.32%
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$147.61
-1.6%
4.893 of 5 stars
3.00$211.33 43.2%10News Coverage
Analyst Forecast

This page (NASDAQ:BIB) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners